We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Capillary Blood Analysis Validated for POC System

By LabMedica International staff writers
Posted on 22 Aug 2017
Print article
Image: The epoc POC blood analysis system (Photo courtesy of Alere).
Image: The epoc POC blood analysis system (Photo courtesy of Alere).
The gold standard samples for blood gas analysis are arterial blood collected from arterial catheter or by arterial puncture, but the proper sampling of arterial blood is difficult, painful, and sometimes risky to obtain in patient in transport.

Capillary blood samples have become an alternative to arterial blood for blood gas and other critical tests especially in patient transport, because they are least painful and easiest to obtain, from various sites such as fingertip, heel or earlobe.

Laboratory scientists at Baylor College of Medicine (Houston, TX, USA) used 10 venous blood samples to assess the correlation between reference methods and the capillary mode testing, which refers to collecting sample with the capillary tube provided followed by selecting “capillary” as the sample type on a Point of Care Blood Analysis System. Twenty three study participants (17 females, six males) were recruited to donate capillary blood for the reference range concordance study.

For method comparison of creatinine, fresh venous blood samples were collected and centrifuged within an hour from collection, and were tested on the predicate analyzer Vitros 5600 Integrated System. For method comparison of Na+, K+, Cl-, Ca2+, glucose, lactate, hematocrit, hemoglobin, pO2, pCO2, and pH, fresh venous blood samples were collected in heparinized vacutainer tubes, and were tested on the predicate analyzer GEM Premier 4000 with a minimum volume of 150 µL and on epoc Point of Care Blood Analysis System under the capillary mode.

The scientists found that acceptable correlations with other chemistry analyzers were found for all analytes except for ionized calcium. Accordance to the reference ranges of greater than 85% were observed with the exception of pO2 and chloride. Their data supports the implementation of the capillary blood tests on the epoc system with cautions needed for calcium. Chloride and pO2 tests are not suitable for capillary blood sampling.

The authors concluded that their study demonstrated that the epoc Point of Care Blood Analysis System may be one option of blood gas analyses and other critical tests using capillary blood in patient transport. The results are informative to institutions where pre-hospital and inter-hospital laboratory testing on capillary blood is a critical component of patient point of care testing. The study was available on line since July 19, 2017, on the journal Practical Laboratory Medicine.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
New
PSA Test
Humasis PSA Card

Print article

Channels

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.